🇺🇸 FDA
Patent

US 10835755

Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections

granted A61KA61K41/0052A61K45/06

Quick answer

US patent 10835755 (Method of using laser-induced optoacoustics for the treatment of drug-resistant microbial infections) held by United States of America as represented by the Secretary of the Air Force expires Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States of America as represented by the Secretary of the Air Force
Grant date
Tue Nov 17 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K41/0052, A61K45/06, A61K47/6835, A61K47/6923